Arvind M. Hundal
Private Equity Investor bei Accelerace Management A/S
Profil
Arvind M.
Hundal is a professional with a doctorate degree from the University of Glasgow and an undergraduate degree from King's College London.
She is currently working as a Business Accelerator & Investment Manager at Accelerace Management A.
Previously, she worked as the Chief Business Officer at Zealand Pharma A from 2009 to 2011 and as the Chief Business Officer at Ziarco Pharma Ltd.
Aktive Positionen von Arvind M. Hundal
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerace Management A/S
 Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Private Equity Investor | 01.04.2017 |
Ehemalige bekannte Positionen von Arvind M. Hundal
| Unternehmen | Position | Ende |
|---|---|---|
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Corporate Officer/Principal | 01.02.2017 |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
Ausbildung von Arvind M. Hundal
| King's College London | Undergraduate Degree |
| University of Glasgow | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Accelerace Management A/S
Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Finance |